Ping Fu Chen from 109 Curtis Ave APT 907, Quincy, MA 02169, age 82

Us Patents

Substitued [1,2,4]Triazolo[1,5-A]Pyrazines As Dipeptidyl Peptidase-Iv Inhibitors For The Treatment Or Prevention Of Diabetes
view source
US Patent:

7812027, Oct 12, 2010
Filed:

May 11, 2007
Appl. No.:

12/226584
Inventors:

Tesfaye Biftu - Freehold NJ, US
Ping Chen - Edison NJ, US
Danqing Feng - Green Brook NJ, US
Ann E. Weber - Scotch Plains NJ, US
Assignee:

Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:

A61K 31/50
US Classification:

51425505, 544350, 549424
Abstract:

The present invention is directed to novel substituted aminotetrahydropyrans of structural formula I which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.

Aminotetrahydropyrans As Dipeptidyl Peptidase-Iv Inhibitors For The Treatment Or Prevention Of Diabetes
view source
US Patent:

7910596, Mar 22, 2011
Filed:

Feb 9, 2007
Appl. No.:

12/223143
Inventors:

Tesfaye Biftu - Freehold NJ, US
Charles G Caldwell - Dallas TX, US
Ann E. Weber - Scotch Plains NJ, US
Ping P Chen - Edison NJ, US
Xiaoxia Qian - New York NY, US
Danqing Feng - Branchburg NJ, US
Jason M. Cox - East Windsor NJ, US
Assignee:

Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:

A01N 43/90
A61K 31/519
C07D 487/00
US Classification:

5142651, 544280
Abstract:

The present invention is directed to novel substituted aminotetrahydropyrans of structural formula I which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.

Substituted 5,6,7,8-Tetrahydropyrido[4,3-D]Pyrimidines As Dipeptidyl Peptidase-Iv Inhibitors For The Treatment Or Prevention Of Diabetes
view source
US Patent:

7928112, Apr 19, 2011
Filed:

Aug 27, 2010
Appl. No.:

12/869869
Inventors:

Tesfaye Biftu - Freehold NJ, US
Ping Chen - Edison NJ, US
Danqing Feng - Green Brook NJ, US
Ann E. Weber - Scotch Plains NJ, US
Assignee:

Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:

A61K 31/519
US Classification:

5142641, 544279, 549424
Abstract:

The present invention is directed to novel substituted aminotetrahydropyrans of structural formula I which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.

Aminotetrahydropyrans As Dipeptidyl Peptidase-Iv Inhibitors For The Treatment Or Prevention Of Diabetes
view source
US Patent:

8143289, Mar 27, 2012
Filed:

Nov 12, 2009
Appl. No.:

12/616831
Inventors:

Tesfaye Biftu - Freehold NJ, US
Ping Chen - Edison NJ, US
Jason M. Cox - East Windsor NJ, US
Ann E. Weber - Scotch Plains NJ, US
Assignee:

Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:

A61K 31/4439
A61K 31/4162
A61P 3/10
C07D 401/14
C07D 487/04
US Classification:

514338, 514407, 5462757, 5483605
Abstract:

The present invention is directed to novel substituted aminotetrahydropyrans of structural formula I which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.

Aminotetrahydropyrans As Dipeptidyl Peptidase-Iv Inhibitors For The Treatment Or Prevention Of Diabetes
view source
US Patent:

8455533, Jun 4, 2013
Filed:

Aug 23, 2010
Appl. No.:

13/390538
Inventors:

Tesfaye Biftu - Freehold NJ, US
Ping Chen - Edison NJ, US
Danqing Feng - Green Brook NJ, US
Xiaoxia Qian - New York NY, US
Assignee:

Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:

A61K 31/4162
C07D 231/00
US Classification:

514406, 5483605
Abstract:

The present invention is directed to novel substituted aminotetrahydropyrans of structural formula I which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.

Compounds Useful For Treating Disorders Related To Trpa1
view source
US Patent:

8530487, Sep 10, 2013
Filed:

Jan 29, 2010
Appl. No.:

12/696618
Inventors:

Xinyuan Wu - Newton MA, US
Spencer David Kimball - East Windsor NJ, US
Ping Chen - Franklin Park NJ, US
Ding Zhou - Shanghai, CN
Shaoping Peng - Shanghai, CN
Assignee:

Hydra Biosciences, Inc. - Cambridge MA
International Classification:

A01N 43/54
A61K 31/505
C07D 239/00
C07D 471/00
US Classification:

514267, 544250
Abstract:

Compounds and compositions for treating disorders related to TRPA1 are described herein.

Aminotetrahydropyrans As Dipeptidyl Peptidase-Iv Inhibitors For The Treatment Or Prevention Of Diabetes
view source
US Patent:

20120149637, Jun 14, 2012
Filed:

Feb 17, 2012
Appl. No.:

13/398887
Inventors:

Tesfaye Biftu - Freehold NJ, US
Ping Chen - Edison NJ, US
Jason M. Cox - East Windsor NJ, US
Ann E. Weber - Scotch Plains NJ, US
International Classification:

A61K 31/4162
A61K 38/28
A61P 3/10
C07D 487/04
US Classification:

514 65, 5483605, 514407
Abstract:

The present invention is directed to novel substituted aminotetrahydropyrans of structural formula I which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.

Novel Cyclic Azabenzimidazole Derivatives Useful As Anti-Diabetic Agents
view source
US Patent:

20130123237, May 16, 2013
Filed:

Feb 23, 2012
Appl. No.:

13/812536
Inventors:

Rajan Anand - Fanwood NJ, US
James M. Apgar - Highland Park NJ, US
Tesfaye Biftu - Freehold NJ, US
Ping Chen - Edison NJ, US
Lin Chu - Scotch Plains NJ, US
Vincent J. Colandrea - North Brunswick NJ, US
Guizhen Dong - Dayton NJ, US
James F. Dropinski - Colts Neck NJ, US
Danqing Feng - Green Brook NJ, US
Jacqueline D. Hicks - Scotch Plains NJ, US
Jinlong Jiang - Scotch Plains NJ, US
Alexander J. Kim - Morganville NJ, US
Kenneth J. Leavitt - Plainsboro NJ, US
Bing Li - Towaco NJ, US
Xiaoxia Qian - New York NY, US
Iyassu Sebhat - Jersey City NJ, US
Lan Wei - Berkeley Heights NJ, US
Robert R. Wilkening - Maplewood NJ, US
Zhicai Wu - Montvale NJ, US
Assignee:

Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:

A61K 31/5377
A61K 31/437
A61K 31/4985
A61K 31/351
A61K 31/397
A61K 31/4412
C07D 471/04
A61K 31/496
US Classification:

51421021, 546118, 514303, 544362, 51425304, 544127, 5142342
Abstract:

Novel compounds of structural formula (I) are activators of AMP-protein kinase and are useful in the treatment, prevention and suppression of diseases mediated by the AMPK-activated protein kinase. The compounds of the present invention are useful in the treatment of Type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and hypertension.

Lawyers & Attorneys

Ping Chen, New York NY - Lawyer

view source

Address:

Wilson Elser Moskowitz Edelman & Dick LLP
150 E 42Nd St, New York, NY 10017
2124903000 (Office)

Licenses:

New York - Currently registered 2004

Education:

Rutgers University

Name / Title

Company / Classification

Phones & Addresses

Ping Chen
Owner

Hunan Star
Restaurants

8116 Olive Blvd, St Louis, MO 63130-2023

Ping Chen
President, Principal

TEPPANYAKI AND SUPREME BUFFET CT INC
Eating Place · Eating Places

355 Huntington Tpke, Bridgeport, CT 06610
17 E Broadway STE 307, New York, NY 10002
1548 Dixwell Ave, Bridgeport, CT 06604

Ping Chen
Manager

Beijing
Eating Place

58 Main St, South River, NJ 08882
7322573888

Ping Chen
Director, Secretary

Ching Chang Produce Co
Whol Fruits/Vegetables

123 Newmarket Sq, Boston, MA 02118
6174642060

Ping Chen

2 DO Again LLC
Ret Women's Clothing

1410 Broadway, New York, NY 10018
2123545333

Ping Chen

CHEN NAIL SALON INC

7301 5 Ave, Brooklyn, NY 11209

Ping Chen
Owner

Red Apple Chinese Restaurant
Eating Place

325 Ct St, Brooklyn, NY 11231
7188751628

Ping Chen
Principal

Lepetit Salon
Beauty Shop

7301 5 Ave, Brooklyn, NY 11209
7920 5 Ave, Brooklyn, NY 11209
7187489272

License Records

Ping Chen

License #:

4704224720 - Expired

Category:

Nursing

Issued Date:

May 11, 2000

Expiration Date:

Mar 31, 2003

Type:

Ping Ping Chen

Address:

Quincy, MA 02169

License #:

21094308 - Expired

Issued Date:

Sep 1, 2009

Expiration Date:

Jan 29, 2013

Type:

Cosmetologist Type 2

Resumes

Ping Chen Westborough, MA

view source

Work:

Lilliputian Systems

Sep 2009 to 2000
Sr. Process Development Engineer SOLASTA
Newton, MA
Oct 2009 to Mar 2010
Sr. Process Engineer ANALOG DEVICES
Cambridge, MA
May 2007 to Oct 2009
Sr. Process Engineer SKYWORKS SOLUTIONS
Woburn, MA
May 2006 to May 2007
Process Engineer UNIVERSITY OF ALABAMA
Tuscaloosa, AL
Aug 2001 to Sep 2005
Research Assistant

Education:

University of Alabama
Tuscaloosa, AL
Aug 2005
Ph.D. in Chemical Engineering Research Institute of Petroleum Processing
2000
M.S. in Chemical Engineering Jiangsu Institute of Petrochemical Technology
1995
B.E. in Chemical Engineering

Ping Chen Livingston, NJ

view source

Work:

FORTRESS Investment Group

Mar 2011 to Present
Product controller, Middle Office CITCO Fund Services Ltd

Sep 2007 to Mar 2011
Manager, P&L Analytical / Valuation Bank of New York Mellon, NJ
New York, NY
Nov 2005 to Aug 2007
Analyst II, Global Asset Management

Education:

Temple University, Fox Business School
Philadelphia, PA
May 2005
Master in Finance Philadelphia University
Philadelphia, PA
May 2003
Bachelor in Computer & Information Science

Medicine Doctors

Ping Chen

view source

Specialties:

Physical Medicine & Rehabilitation

Work:

Southeastern Integrated MedicalSoutheast Integrated Medical Rehabilitation Medicine
1315 NW 21 Ave STE 2, Chiefland, FL 32626
3524931655 (phone), 3524908641 (fax)

Languages:

English

Description:

Ms. Chen works in Chiefland, FL and specializes in Physical Medicine & Rehabilitation. Ms. Chen is affiliated with UF Health Shands Rehabilitation Hospital.